Prime Therapeutics : Processing Update - Amphetamine-dextroamphetamine capsules extended release - Covered Persons of Regence Health Plans

Effective January 1, 2018

Author: Erica Lawrence/Thursday, December 7, 2017/Categories: APCI Choice

Effective January 1, 2018 amphetamine-dextroamphetamine capsules extended release (i.e., generic Adderall XR) will become a preferred product. Previously, the branded Adderall XR was the preferred product over the generic for Regence Health Plans. This change will apply to Covered Persons of:

*Please see attachment for more information

Comments are only visible to subscribers.